Daniel McGahn
Director Ejecutivo en AMERICAN SUPERCONDUCTOR CORPORATION .
Fortuna: 13 M $ al 30/04/2024
Perfil
Daniel Patrick McGahn is currently the Chairman, President & Chief Executive Officer at American Superconductor Corp.
He previously served as a Director at BioDE Ventures Ltd.
and as an Independent Director at Exro Technologies, Inc. from 2017 to 2021.
McGahn also held the position of Chief Marketing Officer & Executive Vice President at Konarka Technologies, Inc. from 2003 to 2006.
Additionally, he served as the Chief Operating Officer & General Manager at Hyperion Catalysis International, Inc. McGahn obtained his undergraduate and graduate degrees from the Massachusetts Institute of Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/05/2024 | 1 069 113 ( 2.96% ) | 13 M $ | 30/04/2024 |
Cargos activos de Daniel McGahn
| Empresas | Cargo | Inicio |
|---|---|---|
| AMERICAN SUPERCONDUCTOR CORPORATION | Director Ejecutivo | 16/06/2011 |
Antiguos cargos conocidos de Daniel McGahn.
| Empresas | Cargo | Fin |
|---|---|---|
| EXRO TECHNOLOGIES INC. | Director/Miembro de la Junta | 19/08/2021 |
Konarka Technologies, Inc.
 Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Ventas & Marketing | 01/01/2006 |
BioDE Ventures Ltd.
 BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | - |
Hyperion Catalysis International, Inc.
 Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Director de Operaciones | - |
Formación de Daniel McGahn.
| Massachusetts Institute of Technology | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AMERICAN SUPERCONDUCTOR CORPORATION | Producer Manufacturing |
| EXRO TECHNOLOGIES INC. | Producer Manufacturing |
| Empresas privadas | 3 |
|---|---|
Konarka Technologies, Inc.
Konarka Technologies, Inc. SemiconductorsElectronic Technology Konarka Technologies, Inc. developed nano-enabled polymer photovoltaic materials. The company was founded in 2001 and was headquartered in Lowell, MA. | Electronic Technology |
Hyperion Catalysis International, Inc.
Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Producer Manufacturing |
BioDE Ventures Ltd.
BioDE Ventures Ltd. BiotechnologyHealth Technology BioDE Ventures Ltd. develops biotechnology and pharmaceutical products. Its primary product is the omiganan gel, which has completed Phase III studies, a cationic peptide for the treatment of rosacea and dermatological diseases. The company is headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Daniel McGahn